Viewing Study NCT01285167


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-24 @ 11:47 PM
Study NCT ID: NCT01285167
Status: COMPLETED
Last Update Posted: 2016-10-31
First Post: 2011-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COPD View
None Quality of life View
None lung function View
None spirometry View
None roflumilast View
None Daxas View
None severe COPD View